Tag Archive for: Adcendo

Novo Seeds Provides Business Update on a Record Year – Building Exceptional Companies for Global Impact

/in

Over US$ 550 million raised by portfolio companies in 2021 IO Biotech IPO on US NASDAQ Forendo Pharma acquired for nearly US$ 1 billion Muna launched with world-leading science to advance latest scientific breakthroughs in neuroscience Adcendo raised US$ 60 million Series A to deliver next-generation Antibody-Drug Conjugates Hemab raised US$ 50 million Series A to […]

Read more

Adcendo Further Strengthens Management Team and Scientific Advisory Board with Appointment of International ADC Leaders

/in

 Building the team with experienced biotech experts and renowned leaders in the ADC field  Underscores company’s commitment to progressing lead program on novel ADC target uPARAP Copenhagen, Denmark, December 1st, 2021 – Adcendo, a biotech company focused on the development of breakthrough antibody-drug conjugates (ADCs) for the treatment of underserved cancers, announced today […]

Read more